Published in Mol Cell Endocrinol on August 15, 2013
Oestrogen receptors in breast cancer: basic mechanisms and clinical implications. Ecancermedicalscience (2013) 0.97
Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation. J Clin Med (2016) 0.81
Suppressive Effects of Tea Catechins on Breast Cancer. Nutrients (2016) 0.81
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy. Mol Cell Endocrinol (2015) 0.80
AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression. J Biol Chem (2016) 0.78
Multiple Functions of the Eya Phosphotyrosine Phosphatase. Mol Cell Biol (2015) 0.78
MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis. Oncotarget (2016) 0.78
Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts. Horm Cancer (2016) 0.75
Cancer therapy using natural ligands that target estrogen receptor beta. Chin J Nat Med (2015) 0.75
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity. Mol Cell Endocrinol (2016) 0.75
MTA1 regulation of ERβ pathway in salivary gland carcinoma cells. Biochem Biophys Res Commun (2015) 0.75
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility. Front Endocrinol (Lausanne) (2016) 0.75
Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ. Oncotarget (2016) 0.75
Sex-difference affects disease progression in the MRMT-1 model of cancer-induced bone pain. F1000Res (2015) 0.75
Recent perspectives of breast cancer prognosis and predictive factors. Oncol Lett (2016) 0.75
Phytoestrogen (+)-pinoresinol exerts antitumor activity in breast cancer cells with different oestrogen receptor statuses. BMC Complement Altern Med (2016) 0.75
Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines. Breast Cancer (Dove Med Press) (2017) 0.75
Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in Northern Europe. PLoS One (2008) 3.09
Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol (2003) 2.38
Estrogen receptor beta: an overview and update. Nucl Recept Signal (2008) 1.97
Liver X receptor in cholesterol metabolism. J Endocrinol (2009) 1.59
The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol (2011) 1.52
Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver. Mol Endocrinol (2007) 1.50
Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes (2012) 1.44
Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab (2008) 1.40
Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res (2009) 1.40
Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene (2003) 1.39
Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol (2006) 1.36
Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res (2007) 1.35
The transcription factor encyclopedia. Genome Biol (2012) 1.28
The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc Natl Acad Sci U S A (2008) 1.27
Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice. Proc Natl Acad Sci U S A (2013) 1.26
Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res (2010) 1.20
Genome wide association study identifies KCNMA1 contributing to human obesity. BMC Med Genomics (2011) 1.18
Estrogen signaling via estrogen receptor {beta}. J Biol Chem (2010) 1.12
Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol Pharmacol (2002) 1.12
Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr (2005) 1.08
Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma. PLoS One (2010) 1.08
Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk. Int J Cancer (2003) 1.06
Difference in skeletal muscle function in males vs. females: role of estrogen receptor-beta. Am J Physiol Endocrinol Metab (2004) 1.04
Differences in metabolite profile between blood plasma and serum. Anal Biochem (2010) 1.03
Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. Pharmacogenet Genomics (2006) 1.01
Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem Biophys Res Commun (2012) 1.01
Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases. Curr Opin Pharmacol (2010) 1.00
Estrogen receptor beta polymorphism is associated with prostate cancer risk. Clin Cancer Res (2006) 0.99
Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression. Mol Pharmacol (2004) 0.96
Metabolic diseases and cancer risk. Curr Opin Oncol (2012) 0.94
Transgenic mouse models support HCR as an effector gene in the PSORS1 locus. Hum Mol Genet (2004) 0.94
Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells. Biochem Biophys Res Commun (2012) 0.94
Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro. Endocrinology (2004) 0.94
Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study. BMC Med Genet (2007) 0.93
Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker. PLoS One (2009) 0.92
Microarray analysis of altered gene expression in ERbeta-overexpressing HEK293 cells. Endocrine (2009) 0.92
Water use sources of desert riparian Populus euphratica forests. Environ Monit Assess (2014) 0.91
Identification of target genes involved in the antiproliferative effect of glucocorticoids reveals a role for nuclear factor-(kappa)B repression. Mol Endocrinol (2004) 0.91
Classification of the carcinogenicity of N-nitroso compounds based on support vector machines and linear discriminant analysis. Chem Res Toxicol (2005) 0.91
Genetic association and gene expression analysis identify FGFR1 as a new susceptibility gene for human obesity. J Clin Endocrinol Metab (2011) 0.91
Fatty acids derived from royal jelly are modulators of estrogen receptor functions. PLoS One (2010) 0.90
Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling. J Pathol (2005) 0.90
Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association. Breast Cancer Res Treat (2003) 0.90
Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril (2008) 0.89
Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr (2006) 0.89
Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study. BMC Med Genet (2009) 0.89
Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action. PLoS One (2013) 0.89
Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells. Carcinogenesis (2012) 0.89
Gold nanocluster-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. ACS Appl Mater Interfaces (2012) 0.87
Developmental toxicity of the environmental pollutant 4-nonylphenol in zebrafish. Neurotoxicol Teratol (2011) 0.87
Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells. J Mol Endocrinol (2009) 0.87
Genomic landscape of positive natural selection in Northern European populations. Eur J Hum Genet (2009) 0.86
RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1. Cancer Res (2010) 0.86
Surface electrocardiogram and action potential in mice lacking urea transporter UT-B. Sci China C Life Sci (2009) 0.86
Purification of functional full-length liver X receptor beta produced in Escherichia coli. Protein Expr Purif (2004) 0.86
GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. Am J Physiol Renal Physiol (2013) 0.86
Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta. Mol Endocrinol (2003) 0.86
Gene expression profiling in adipose tissue indicates different transcriptional mechanisms of liver X receptors alpha and beta, respectively. Biochem Biophys Res Commun (2003) 0.86
Elk1 and SRF transcription factors convey basal transcription and mediate glucose response via their binding sites in the human LXRB gene promoter. Nucleic Acids Res (2007) 0.86
Germ line specific expression of a vasa homologue gene in turbot (Scophthalmus maximus): evidence for vasa localization at cleavage furrows in euteleostei. Mol Reprod Dev (2012) 0.85
Quantitative structure-activity relationship for prediction of the toxicity of polybrominated diphenyl ether (PBDE) congeners. Chemosphere (2006) 0.85
Progesterone inhibits inflammatory response pathways after permanent middle cerebral artery occlusion in rats. Mol Med Rep (2011) 0.85
Identification of estrogen-regulated genes of potential importance for the regulation of trabecular bone mineral density. J Bone Miner Res (2002) 0.85
Use of ramification amplification assay for detection of Escherichia coli O157:H7 and other E. coli Shiga toxin-producing strains. J Clin Microbiol (2005) 0.85
Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose. Pharmacogenet Genomics (2008) 0.85
Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment. Biochemistry (2005) 0.84
Expression of activator protein-1 (AP-1) family members in breast cancer. BMC Cancer (2013) 0.84
Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome. J Clin Pathol (2006) 0.84
GC-TOFMS analysis of metabolites in adherent MDCK cells and a novel strategy for identifying intracellular metabolic markers for use as cell amount indicators in data normalization. Anal Bioanal Chem (2011) 0.84
Effects of estrogen on gene expression profiles in mouse hypothalamus and white adipose tissue: target genes include glutathione peroxidase 3 and cell death-inducing DNA fragmentation factor, alpha-subunit-like effector A. J Endocrinol (2008) 0.83
Effects of two common polymorphisms in the 3' untranslated regions of estrogen receptor beta on mRNA stability and translatability. BMC Genet (2009) 0.83
Nuclear receptors in disease: the oestrogen receptors. Essays Biochem (2004) 0.83
Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms. Exp Mol Med (2009) 0.83
Effects of testosterone and estrogen treatment on lipolysis signaling pathways in subcutaneous adipose tissue of postmenopausal women. Fertil Steril (2007) 0.83
The gene regulatory networks controlled by estrogens. Mol Cell Endocrinol (2010) 0.82
Crocidolite asbestos-induced signal pathway dysregulation in mesothelial cells. Mutat Res (2011) 0.81
Pepsinogen A and C genes in turbot (Scophthalmus maximus): characterization and expression in early development. Comp Biochem Physiol B Biochem Mol Biol (2013) 0.80
Progesterone influences postischemic synaptogenesis in the CA1 region of the hippocampus in rats. Synapse (2011) 0.80
Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization. Chem Biol Drug Des (2013) 0.80
AP-1 is a key regulator of proinflammatory cytokine TNFα-mediated triple-negative breast cancer progression. J Biol Chem (2016) 0.79
Demonstration of UV-dimers in human skin DNA in situ 3 weeks after exposure. Carcinogenesis (2002) 0.79
Gene expression of estrogen receptors in PBMC from patients with Puumala virus infection. Shock (2012) 0.79
Quantitative structure-activity relationship models for prediction of the toxicity of polybrominated diphenyl ether congeners. Environ Sci Technol (2005) 0.78
Human estrogen receptor beta 548 is not a common variant in three distinct populations. Endocrinology (2003) 0.78
OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16. Mol Cell Biochem (2011) 0.78
Sulfite exposure-induced hepatocyte death is not associated with alterations in p53 protein expression. Toxicology (2013) 0.78
A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine. Mol Biosyst (2014) 0.78